February 21st, 2018
Shaorong Deng gets an experimental treatment for cancer of the esophagus that uses his own immune system cells. They have been genetically modified with the gene-editing technique known as CRISPR.
“China is starting to pull ahead of other parts of the world — maybe for the time — in regards to biomedicine,” says Hallam Stevens, an anthropologist at the Nanyang Technological University in Singapore who studies Chinese bioscience. “They’ve been really investing heavily in it over the last couple of decades and it’s starting to pay off in a big way.”